Showing results (81-90 of 296) with videos related to
Sort By:
Pageof 30
Cancer Research|April 1, 1981
Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidineL Teodori, B Barlogie, B Drewinko, et al.Cancer Research|September 1, 1981
Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouseJ J Stragand, B Barlogie, R A White, et al.Cell and Tissue Kinetics|September 1, 1984
Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phaseB Drewinko, L Y Yang, B Barlogie, et al.Seminars in Oncology|October 21, 1999
Novel approaches in myeloma therapyN C Munshi, B Barlogie, K R Desikan, et al.European Journal of Cancer & Clinical Oncology|February 1, 1984
High-dose cytosine arabinoside in multiple myelomaH Kantarjian, R Dreicer, B Barlogie, et al.Critical Reviews in Oncology/Hematology|March 14, 2003
Angiogenesis in hematologic malignanciesT M Moehler, A D Ho, H Goldschmidt, et al.Cancer Research|July 1, 1976
Kinetic response of human lymphoid cells to adriamycin-DNA complex in vitroB Barlogie, B Drewinko, R S Benjamin, et al.The Journal of Clinical Investigation|August 1, 1985
Cytoplasmic immunoglobulin content in multiple myelomaB Barlogie, R Alexanian, M Pershouse, et al.Blood|May 1, 1986
High-dose melphalan with autologous bone marrow transplantation for multiple myelomaB Barlogie, R Hall, A Zander, et al.Current Opinion in Hematology|July 10, 1999
Recent advances in the treatment of multiple myelomaK R Desikan, M V Dhodapkar, N C Munshi, et al.Pageof 30